Five years since its IPO, we check in with Bioalpha, which has seen its business disrupted as a result of the Covid-19 pandemic.

Khoo Hsu Chuang speaks to William Hon, CEO of Bioalpha, to discuss the health supplement company’s path to recovery, its plans for overseas expansion and the overall outlook for 2021.

Image Credit: bioa.com.my